Boulder, CO – According to filings with the U.S. Securities and Exchange Commission, Watchmaker Genomics is raising $40,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Trey Foskett played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Watchmaker Genomics
Watchmaker Genomics combines deep domain expertise in protein engineering with enzyme manufacturing to address the demanding quality, performance and scale requirements of high-growth genomics applications. We see our clients as partners and view technical and supply chain challenges as opportunities for mutual success. Watchmakers best-in-class scientific competencies enable a disruptive approach to life science partnerships.

To learn more about Watchmaker Genomics, visit http://watchmakergenomics.com/

Contact:
Trey Foskett, Chief Executive Officer
303-524-9989
trey.foskett@watchmakergenomics.com
https://www.linkedin.com/in/trey-foskett-6849936/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved